cas9
Kidney Failure
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLCprotein_peptidePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Kidney Failure cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Empagliflozin University Hospital, Basel, Switzerland | Phase 4 | BB |
Dynepo Shire | Phase 3 | B |
EPOETIN DELTA Shire | Phase 3 | B |
Same molecule, other indications
cas9 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →